ArticleBMC pediatrics2025
Clinical characteristics and risk factors for recurrence of Kikuchi-Fujimoto disease in children: a case-control study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThis study was performed to summarize the clinical and laboratory features of children with Kikuchi-Fujimoto disease (KFD). The risk factors of KFD recurrence were analyzed.
methodsA retrospective case-control study was conducted on children who underwent lymph node biopsy in the department of infectious diseases of Beijing Children's Hospital from April 2018 to April 2022. The clinical manifestations and treatment of children with KFD were summarized, and the clinical characteristics of children with KFD and the control group were compared. The clinical characteristics of FANA (fluorescent antinuclear antibody) positive group and FANA negative group in children with KFD were compared. The children with KFD were divided into recurrence group and non-recurrence group, and the risk factors for recurrence of KFD were analyzed.
resultsA total of 359 children with lymph node biopsy were included in the study, including 239 children with KFD. The ratio of male to female was 1.85:1 and the average age was (9.78 ± 2.91) years. Two hundred and thirty-five (98.3%) KFD children had fever and two hundred and thirty-six cases (98.7%) of KFD children had cervical lymph node enlargement. A total of 208 (87.0%) KFD children had a decrease in white blood cell count during the course of the disease. The proportions of lymph node enlargement with tenderness, oral ulcer and leucopenia in the KFD group were significantly higher than those in the control group (P < 0.05). The proportion of multiple lymph node involvement in the KFD group was significantly lower than that in the control group (P < 0.05). Among the 239 cases, 51 cases (21.3%) were treated with corticosteroid and 10 received intravenous immunoglobulin therapy. Among the 239 patients with KFD, 30 (12.6%) had recurrence and 12 of them had recurrence within 3 months after discharge. In univariate analysis, recurrence was associated with positive antinuclear antibody and corticosteroid therapy (P < 0.05).No risk factor for recurrence was identified in multivariable analysis (P > 0.05).
conclusionsKFD in children is more common in males and mostly occurs at school age. KFD in children is characterized by tenderness in the lymph node and leukopenia with less multiple lymph node involvement. All patients should be monitored for recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.